Welcome to our dedicated page for Therma Bright news (Ticker: TBRIF), a resource for investors and traders seeking the latest updates and insights on Therma Bright stock.
Therma Bright Inc. (TBRIF) delivers cutting-edge advancements in diagnostic technologies and medical devices through strategic partnerships and proprietary innovations. This news hub provides investors and healthcare professionals with verified updates on the company's progress in respiratory health solutions, vascular compression therapies, and stroke care technologies.
Access official press releases covering regulatory milestones like HCPCS designations, AI-driven diagnostic platform developments, and strategic collaborations with industry pioneers. Our curated collection ensures transparent tracking of Therma Bright's dual growth strategy: direct commercialization of medical devices and returns from targeted investments.
Discover updates categorized for quick navigation, including product approvals, clinical trial results, partnership announcements, and financial disclosures. All content is sourced directly from company filings and vetted industry channels to maintain accuracy.
Bookmark this page for streamlined access to Therma Bright's evolving role in shaping next-generation healthcare solutions. Check regularly for insights into how the company balances technological innovation with strategic market expansion.
Therma Bright, a developer of diagnostic and medical device technologies, announces a non-brokered private placement offering up to $1,000,000 by issuing 100,000,000 units at $0.01 per unit. Each unit includes one common share and a half-warrant, with full warrants exercisable over three years at $0.05 in the first year and $0.10 in the subsequent years. The proceeds will fund their Digital Cough technology, pay debts, and support general working capital. The offering is expected to close by June 7, 2024, pending regulatory approvals. Additionally, Therma Bright has granted stock options and warrants to directors, officers, consultants, and entered into debt settlements issuing common shares.